We argue that age, AD risk factor genes and systemic factors can selectively injure oligodendrocytes, OPCs and myelin that results in cholesterol dysmetabolism which tips the scales toward Abeta retention and aggregation and amyloid plaque formation. Here, APP is linked to Alzheimer disease.